Pharmacotherapy for Mood Disorders in Pregnancy
نویسندگان
چکیده
منابع مشابه
Electroconvulsive therapy for mood disorders in pregnancy.
Electroconvulsive therapy (ECT) offers a treatment option for mood disorders during pregnancy. We retrospectively examined 12 pregnant patients who were treated with ECT for their mood disorders. The mean ± SD age of the patients was 28.1 ± 4.8 years. The mean ± SD number of ECTs performed was 9.8 ± 4.5. The mean ± SD Clinical Global Impression score was decreased from 6 to 2.6 ± 0.7 with ECT. ...
متن کاملNeuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.
Current treatments for psychiatric disorders were developed with the aim of providing symptomatic relief rather than reversing underlying abnormalities in neuroplasticity or neurodevelopment that might contribute to psychiatric disorders. This review considers the possibility that psychiatric treatments might be developed that target neuroplasticity deficits or that manipulate neuroplasticity i...
متن کاملMOOD DISORDERS: BIPOLAR AND MAJOR DEPRESSIVE DISORDERS Pharmacotherapy Self-Assessment Program, 5th Edition
1. Articulate the differences between the clinical presentation and course of illness for unipolar and bipolar disorders. 2. Formulate appropriate treatment recommendations, including the rationale for treatment selection, for a patient experiencing an acute exacerbation of a mood disorder. 3. Provide appropriate monitoring parameters for pharmacological treatment, target symptoms, and potentia...
متن کاملThe management of mood disorders in pregnancy: alternatives to antidepressants.
The management of mood disorders during pregnancy is complex due to risks associated with medication use and risks associated with untreated depression. Antidepressant use during pregnancy is an exposure for the unborn child, and it currently remains unclear what long-term repercussions there might be from this exposure, though available data are reassuring. On the other hand, there are risks f...
متن کاملPharmacotherapy for acid/peptic disorders.
In the 1970s, the identification of the histamine H2-receptor by Black and the subsequent development of histamine H2-receptor antagonists revolutionized our understanding and treatment of acid/peptic disorders. More recently, the identification of hydrogen-potassium-stimulated adenosine triphosphatase (H+/K(+)-ATPase) as the proton pump of the parietal cell and the recognition of the prominent...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Psychopharmacology
سال: 2014
ISSN: 0271-0749
DOI: 10.1097/jcp.0000000000000087